Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KND
3226
DELISTED
Kindred Healthcare
KND
| $789K | ﹤0.01% |
58,772
-132,417
| -69% | -$1.9M |
2013 Q2
1 quarter
|
|
3227
PUT
RenaissanceRe
RNR
$13.5B
| $788K | ﹤0.01% |
8,700
+1,700
| +24% | +$148K |
2013 Q2
1 quarter
|
|
3228
Booz Allen Hamilton
BAH
$8.1B
| $787K | ﹤0.01% |
+40,744
| New | +$797K |
2013 Q3
0 quarters
|
|
3229
eHealth
EHTH
$21.5M
| $787K | ﹤0.01% |
24,413
-20,183
| -45% | -$556K |
2013 Q2
1 quarter
|
|
|
IRBT
3230
CALL
DELISTED
iRobot
IRBT
| $787K | ﹤0.01% |
20,900
-3,800
| -15% | -$136K |
2013 Q2
1 quarter
|
|
3231
CALL
Carpenter Technology
CRS
$19.3B
| $784K | ﹤0.01% |
13,500
+7,500
| +125% | +$400K |
2013 Q2
1 quarter
|
|
3232
Fortune Brands Innovations
FBIN
$4.6B
| $784K | ﹤0.01% |
22,042
-242,186
| -92% | -$8.26M |
2013 Q2
1 quarter
|
|
|
IRF
3233
DELISTED
INTL RECTIFIER CORP
IRF
| $782K | ﹤0.01% |
31,584
-46,420
| -60% | -$1.12M |
2013 Q2
1 quarter
|
|
3234
CALL
Pricesmart
PSMT
$5.27B
| $781K | ﹤0.01% |
8,200
-2,300
| -22% | -$207K |
2013 Q2
1 quarter
|
|
|
CAA
3235
CALL
DELISTED
CalAtlantic Group, Inc.
CAA
| $781K | ﹤0.01% |
19,740
+4,680
| +31% | +$185K |
2013 Q2
1 quarter
|
|
3236
CALL
Universal Health Services
UHS
$10.4B
| $780K | ﹤0.01% |
10,400
-9,200
| -47% | -$642K |
2013 Q2
1 quarter
|
|
3237
PUT
Kirby Corp
KEX
$7.28B
| $779K | ﹤0.01% |
9,000
+600
| +7% | +$50.3K |
2013 Q2
1 quarter
|
|
3238
CALL
Crown Holdings
CCK
$11.5B
| $778K | ﹤0.01% |
18,400
+9,400
| +104% | +$411K |
2013 Q2
1 quarter
|
|
|
PGNX
3239
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $778K | ﹤0.01% |
154,547
-242,707
| -61% | -$1.32M |
2013 Q2
1 quarter
|
|
3240
PUT
CoreCivic
CXW
$3.31B
| $777K | ﹤0.01% |
22,500
+13,800
| +159% | +$462K |
2013 Q2
1 quarter
|
|
3241
CALL
Innoviva
INVA
$1.48B
| $777K | ﹤0.01% |
23,579
-12,658
| -35% | -$394K |
2013 Q2
1 quarter
|
|
|
AMSG
3242
DELISTED
Amsurg Corp
AMSG
| $776K | ﹤0.01% |
19,554
-62,195
| -76% | -$2.42M |
2013 Q2
1 quarter
|
|
3243
CALL
Belden
BDC
$4.39B
| $775K | ﹤0.01% |
12,100
-2,600
| -18% | -$152K |
2013 Q2
1 quarter
|
|
|
CY
3244
CALL
DELISTED
Cypress Semiconductor
CY
| $774K | ﹤0.01% |
82,900
+20,000
| +32% | +$233K |
2013 Q2
1 quarter
|
|
|
DMND
3245
CALL
DELISTED
DIAMOND FOODS, INC.
DMND
| $773K | ﹤0.01% |
32,800
-16,800
| -34% | -$362K |
2013 Q2
1 quarter
|
|
3246
CALL
Arrow Electronics
ARW
$12.3B
| $772K | ﹤0.01% |
15,900
+9,200
| +137% | +$422K |
2013 Q2
1 quarter
|
|
3247
CALL
TE Connectivity
TEL
$63.8B
| $772K | ﹤0.01% |
14,900
+2,600
| +21% | +$130K |
2013 Q2
1 quarter
|
|
|
BRY
3248
CALL
DELISTED
BERRY PETROLEUM CO CL A
BRY
| $772K | ﹤0.01% |
17,900
-33,900
| -65% | -$1.41M |
2013 Q2
1 quarter
|
|
|
OCR
3249
PUT
DELISTED
OMNICARE INC
OCR
| $771K | ﹤0.01% |
13,900
-23,600
| -63% | -$1.26M |
2013 Q2
1 quarter
|
|
3250
CONMED
CNMD
$1.39B
| $770K | ﹤0.01% |
+22,644
| New | +$739K |
2013 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.